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Abstract
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Minimally invasive procedures are becoming increasingly more common in surgery. However, the
biomaterials capable of delivering biomimetic, three-dimensional (3D) functional tissues in a
minimally invasive manner and exhibiting ordered structures after delivery are lacking. Herein, we
reported the fabrication of gelatin methacryloyl (GelMA)-coated, 3D expanded nanofiber scaffolds
and their potential applications in minimally invasive delivery of 3D functional tissue constructs
with ordered structures and clinically appropriate sizes (4 cm × 2 cm × 1.5 mm). GelMA-coated,
expanded 3D nanofiber scaffolds produced by combining electrospinning, gas-foaming expansion,
hydrogel coating, and crosslinking are extremely shape recoverable after release of compressive
strain, displaying a superelastic property. Such scaffolds can be seeded with various types of cells,
including dermal fibroblasts, bone marrow-derived mesenchymal stem cells, and human neural
stem/precursor cells to form 3D complex tissue constructs. Importantly, the developed 3D tissue
constructs can be compressed and loaded into a 4-mm diameter glass tube for minimally invasive
delivery without compromising the cell viability. Taken together, the method developed in this
*
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study could hold great promise for transplantation of biomimetic, 3D functional tissue constructs
with well-organized structures for tissue repair and regeneration using minimally invasive
procedures like laparoscopy and thoracoscopy.

Keywords
expanded nanofiber scaffolds; stem cells; 3D tissue constructs; ordered structure; minimally
invasive delivery
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Based on tissue engineering and regenerative medicine principles, three-dimensional (3D)
tissue constructs with a variety of functions and complex structures have been established
for surgical transplantations to repair many types of tissues, often necessitating invasive
surgical procedures.1-4 However, invasive surgical implantations are associated with an
increased risk for perioperative and postoperative complications (e.g., infections).5
Researchers have attempted to develop other approaches for delivering cells in a minimally
invasive manner (e.g., injection), including cell solutions, mixing cells with hydrogels, cellencapsulated hydrogel beads, cell-seeded microparticles/microspheres, cell aggregates/
organoids, cell microdroplets, and cell sheet fragments.6-15 However, these methods failed to
supply 3D tissue constructs with specifically ordered structures and instantaneous
functionality. Some of the approaches even led to low cell retention and survival rate and
eventually failed to repair the targeted tissue defects after delivery.6,16 There is a great need
to develop 3D functional tissue constructs with well-organized structures that can be
delivered through minimally invasive procedures (e.g., without fully opening the chest).

Author Manuscript
Author Manuscript

Towards this end, several types of materials/scaffolds have been investigated for minimally
invasive delivery of cells/tissues. Interconnected macroporous cryogels made of alginate,
gelatin, hyaluronic acid (HA), HA-co-gelatin, and poly(ethylene glycol) diacrylate
(PEGDA) with shape-memory properties were reported in many predefined geometries,
which can be rehydrated with a suspension of cells (e.g., chondrocytes, mesenchymal stem
cells (MSCs), fibroblasts, and neurons) and/or growth factors (e.g., vascular endothelial
growth factor (VEGF)) and compressed into smaller forms and delivered through a small
catheter or syringe injection for enhancing cell retention and revascularization.17-19 Porous
collagen-coated carboxymethylcellulose microscaffolds seeded with OP9 mesenchymal cells
and hematopoietic stem and progenitor cells (HSPCs) after in vitro co-culture were
harvested as a paste-like living injectable niche through precisely controlled dehydration,
preserving HSPC function.20 Flexible shape-memory poly(oxymethylene maleate
(anhydride) citrate) scaffolds fabricated using a combination of conventional soft
lithography and injection molding were seeded with cardiomyocytes to form cardiac patches
(1 cm × 1 cm × 0.1 mm), which can regain their initial shape without influencing cell
survival and function after delivery through a small orifice.21 Other than the shape-memory
scaffolds, heart valve scaffolds made of polyglycolide acid mesh coated with poly-4hydroxybutyrate with seeding of myofibroblasts were delivered in a minimally invasive
manner in combination with self-expandable stents.22 However, these scaffolds are
associated with issues, including lack of extracellular matrix (ECM)-mimetic topography,
absence of aligned nanotopographic cues, limited size and thickness (non-clinically relevant
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size and thickness), and/or necessitating the assistance from self-expandable stents. The
aligned nanotopographic cues are essential for the repair of tissues (e.g., muscle, nerve, and
tendon) with ordered structure. These tissues show an anisotropic characteristic of ECM
topography. Aligned nanotopographic cues play an important role in regulating cell
morphology and function and guiding ECM deposition. It is critical to use the constructs
with ordered structure for repairing tissues like muscle, nerve, and tendon.

Author Manuscript

Here, we describe a new method for minimally invasive delivery of biomimetic, 3D
functional tissue constructs with ordered structures with clinically relevant size and
thickness for tissue repair as illustrated in Figure 1. The tissue constructs were built based on
3D expanded electrospun nanofiber scaffolds produced by our two recent vital findings. One
is that innovative gas-foaming technology can expand 2D electrospun nanofiber mats to
form 3D expanded scaffolds with layered structure and controlled alignment.24,25 Briefly,
NaBH4 reacting with water produced H2 gas bubbles within nanofiber membranes. As the
reaction proceeded, the H2 gas bubbles grew and/or merged, resulting in the expansion of
nanofiber membranes. The other is that gelatin coating allows expanded nanofiber scaffolds
to be superelastic, compressible, and shape recoverable.26 We hypothesized that i) stem cells
(e.g., bone marrow-derived mesenchymal stem cells (BMSCs) and human neural stem/
progenitor cells (hNSCs)) could be seeded on 3D expanded nanofiber scaffolds and
proliferate and/or differentiate throughout the scaffolds to form 3D tissue constructs; ii) the
engineered 3D tissue constructs could be compressed and delivered to damaged/diseased
tissue sites using minimally invasive surgical procedures such as laparoscopy and
thoracoscopy;26,27 iii) the delivered tissue constructs can return to their original shape after
delivery, and the shape-recovered 3D tissue constructs could effectively repair the damaged
tissues (Figure 1).
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To test our hypothesis, we first fabricated 3D expanded nanofiber scaffolds. Briefly, 1-mm
thick poly(ε-caprolactone) (PCL) nanofiber stripes (4 cm × 1.5 mm) were generated by
electrospinning and cryocutting following our previous studies.28-30 Then, the stripes were
expanded in the NaBH4 solution to form 2-cm wide scaffolds. The expanded 3D scaffolds
were further coated with the 0.05% gelatin methacryloyl (GelMA) solution followed by
crosslinking to enhance their mechanical properties and maintain the nanofibrous
morphology. Figure 2a shows photographs of electrospun nanofiber stripes (4 cm × 1 mm ×
1.5 mm). Figure 2b shows the photographs of 3D expanded nanofiber scaffolds in different
views, indicating the clinically relevant dimensions (4 cm × 2 cm × 1.5 mm) for a cardiac
patch.31 Figure 2c shows scanning electron microscopy (SEM) images of expanded PCL
nanofiber scaffolds, indicating the porous structure and alignment of fibers. Figure 2d shows
SEM images of expanded PCL nanofiber scaffolds after 0.05% GelMA coating and freezedrying. Intriguingly, part of the coated GelMA formed nanofibers throughout the expanded
scaffold, resulting in a hybrid nanofiber scaffold (Figure S1). In contrast with PCL
nanofibers, the GelMA nanofibers were randomly distributed and the diameter of GelMA
nanofibers was not uniform (Figure S1). In contrast, a mass of GelMA sheets and small
amount of GelMA nanofibers were seen throughout the expanded scaffold after 0.1%
GelMA coating (Figure S2). The mechanism of GelMA nanofiber formation could be
similar to the formation of nanofibers by freeze-drying dilute polymer solutions reported in
previous studies as the GelMA concentration was 0.05%.32 As described, during freezeACS Biomater Sci Eng. Author manuscript; available in PMC 2021 August 06.
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drying of a dilute solution, the polymer molecules could be excluded to form nanofibers
because of the small number of polymer molecules available. In addition, a small amount of
GelMA could be directly coated on the surface of PCL nanofibers without altering the
original nanofibrous morphology. We then characterized the superelastic and shape
recoverable properties of 0.05% GelMA coated, 3D expanded nanofiber scaffolds. Figure 3a
shows that 0.05% GelMA coated, 3D expanded PCL nanofiber scaffolds can return to their
original shapes after compression, pulling, rolling, and folding. The cyclic compression tests
further confirmed their superelastic and shape recoverable properties. The 3D expanded
nanofiber scaffolds without GelMA coating deformed after one time of compression in 90%
compressive strain (Figure 3b). As expected, the GelMA-coated nanofiber scaffolds could
return to their original shapes even after 100 times of compression with 90% compressive
strain (Figure 3c). The GelMA coating significantly enhanced the compressive stress of 3D
expanded nanofiber scaffolds in 50%, 70%, and 90% compressive strains, respectively
(Figure 3d). Though the elastic modulus of GelMA-coated nanofiber scaffolds slightly
decreased during the 100 cycles of cyclic compression in 90% compressive strain, the elastic
modulus of GelMA-coated scaffolds were much higher than those of the scaffolds without
coating at the 1st, 25th, 50th, 75th, and 100th cycle of cyclic compression (Figure 3e). In
addition, the GelMA-coated scaffold was able to recover its original shape in water after
compression (Video S1). To understand the mechanism of superelastic and shape
recoverable properties, we performed SEM imaging of cross-sections of 3D expanded
nanofiber scaffolds without and with GelMA coating under compression in different
compressive strains (Figure 3f and 3g). The cross-sections of 3D expanded nanofiber
scaffolds with and without GelMA coating exhibited many arch-shaped pores. After
compression in 50%, 70%, and 90% compressive strains, the height of arches gradually
decreased for both types of scaffolds. After release of compressive strain, the arches can
almost return to their original shapes for GelMA-coated scaffolds (Figure 3g). In contrast,
the arches in 3D expanded nanofiber scaffolds without GelMA coating failed to completely
recover after strain release (Figure 3f). We speculate that the shape recoverable property
could be due to the unique structure of 3D expanded nanofiber scaffolds that have
hierarchically layered architectures forming numerous arches in micro-and millimeter scale.
These arches act as elastic units and the GelMA coatings after crosslinking further reinforce
the arches. Upon the compressive stress, the distortion of scaffolds is mainly attributed to the
squeezing of the arches. The continuous compression causes the densification of arches. The
top and bottom walls of arches eventually contact with each other and form the significant
loading-bearing portion. The cross-linked GelMA coatings may help hold the nanofibers
together at crossing points, nodes, and contacting surfaces, thus providing strong -fatigue
resistance. Therefore, 0.05% GelMA coated nanofiber scaffolds can fully recover their
shapes and retain their structural integrity in each compress-release cycle in different strains.
Compared to 0.5% gelatin-coated nanofiber scaffold, 0.05% GelMA-coated nanofiber
scaffolds showed a better superelastic property based on the cyclic compression test,25
which could be attributed to the intersecting hybrid nanofiber networks. In contrast, in 0.5%
gelatin-coated nanofiber scaffolds, some pores may be blocked by the coated gelatin,
resulting in the reduction of its superelastic property.
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We further cultured different types of cells on 0.05% GelMA-coated, 3D expanded nanofiber
scaffolds (2 cm × 2 cm × 1.5 mm). Green fluorescence protein (GFP)-labeled dermal
fibroblasts were first seeded on 0.05% GelMA-coated, 3D expanded nanofiber scaffolds. It
is evident that the seeded and proliferated fibroblasts were elongated along the direction of
nanofiber alignment after incubation for 1, 3, 7, and 14 days (Figure S3a). Besides, the
seeded fibroblasts proliferated rapidly on the nanofiber scaffolds from day 1 to day 14 as
indicated by cell densities contributed by the fluorescence signals and the quantified CCK-8
assay (Figure S3a and Figure S3b). The cells entirely covered the scaffolds after 14 days of
culture (Figure S3c). BMSCs have been used in repairing and regenerating many tissue
types.33,34 We then demonstrated the attachment and proliferation of BMSCs on 0.05%
GelMA-coated, 3D expanded nanofiber scaffolds. Figure 4a shows confocal microscopy
images of the BMSCs throughout the four regions of scaffolds labeled in Figure S4 after 14
days of incubation. The cell F-actin was stained with Alexa Fluor™ 546 Phalloidin in red,
and the cell nucleus was stained with 4’,6-diamidino-2-phenylindole (DAPI) in blue (Figure
4a). In addition, hNSCs have shown potential in treatment of disease or injuries of the
central and peripheral nervous systems.35,36 We then demonstrated the proliferation and
differentiation of hNSCs on 0.05% GelMA-coated, 3D expanded nanofiber scaffolds. The
hNSCs were able to cover most of the area of the scaffolds after 7 days of proliferation and
14 days of differentiation (Figure 4b). Most neurites extended along the direction of
nanofiber alignment. Some neurites may cross through the nanofiber layers (Figure 4b).

Author Manuscript

We finally examined the effect of minimally invasive delivery on the viability of cells in 3D
shape-recoverable tissue constructs. BMSCs were seeded on 0.05% GelMA-coated, 3D
expanded nanofiber scaffolds (4 cm × 2 cm × 1.5 mm). These cells proliferated for 14 days
to form 3D tissue constructs which were then compressed and loaded into a glass tube
(diameter = 4 mm; length = 15 cm) with assistant of sharp tweezers (Figure 5a). One end of
the glass tube was connected to a filtered air source, and the compressed, BMSCs-seeded
scaffold inside the glass tube was blown into a culture dish containing medium and reexpanded (Figure 5a and Video S2). No significant difference was observed between the cell
viabilities of BMSCs on scaffolds before and after delivery (Figure 5b and Figure 5c).
Similarly, the hNSCs-seeded nanofiber scaffolds can be delivered through the same method
(Video S3). Alternatively, culture medium or saline flowing through the glass tube was able
to push the compressed, cell-seeded scaffolds to the targeted tissue as well (Video S4).

Author Manuscript

In summary, we have demonstrated the fabrication of 0.05% GelMA-coated, 3D expanded
nanofiber scaffolds. Such scaffolds were superelastic and shape recoverable. These scaffolds
after seeding with different cell types can form 3D tissue constructs with ordered structure.
Importantly, these 3D tissue constructs can be delivered via a minimally invasive approach
without compromising the viability of seeded cells. Future studies will be focused on the
investigation of the efficacy of 3D tissue constructs consisting of cells and 0.05% GelMAcoated, 3D expanded nanofiber scaffolds in relevant large animal models.31 In addition,
signaling molecules can be further incorporated to the nanofiber scaffolds to regulate cell
response and enhance tissue repair.30 3D bioprinting could be used to pattern cells
throughout the shape-recoverable nanofiber scaffolds.37 The strategy presented in this study
holds great promise for repairing and regenerating tissues (e.g., heart) using minimally
invasive surgical procedures.
ACS Biomater Sci Eng. Author manuscript; available in PMC 2021 August 06.
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Materials and Methods.
Materials.
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Fabrication of 0.05% GelMA coated, 3D expanded nanofiber scaffolds.
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PCL (Mw= 80 kDa), pluronic-F-127, gelatin, sodium borohydride, Triton X-100 were
purchased from Sigma-Aldrich (St. Louis, MO, USA). Dichloromethane (DCM) and N, Ndimethylformamide (DMF) were purchased from BDH Chemicals (Dawsonville, GA, USA).
Dulbecco's modified eagle medium (DMEM), fetal bovine serum (FBS), and penicillinstreptomycin were obtained from Invitrogen (Carlsbad, CA, USA). Basic fibroblast growth
factor (FGF-2), epidermal growth factor (EGF), brain-derived neurotrophic factor (BDNF),
glial cell-derived neurotrophic factor (GDNF) were obtained from Peptrotech (Rocky Hill,
NJ, USA). The ReNcell Neural Stem Cell Medium was purchased from Millipore (Billerica,
MA, USA). Tuj1 primary antibody and laminin were obtained from Millipore Sigma
(Burlington, MA, USA). Goat anti-mouse IgG H&L (Alexa Fluor® 546) secondary
antibody, Alexa Fluor™ 546 Phalloidin, DAPI were ordered from Abcam (Cambridge, MA,
USA).

SEM characterization.

The PCL/0.5% F-127 nanofiber mat was prepared following our previous study.28-30 The
nanofiber mat (thickness = 1 mm) was immersed in liquid nitrogen and then cut into stripes
(4 cm × 1.5 mm × 1 mm). The nanofiber stripes were subsequently immersed into the 1 M
NaBH4 solution and treated with vacuum for 3 s. The fiber mats were continuously
expanded in the 1 M NaBH4 solution for another 30 s at ambient condition. The expanded
nanofiber scaffolds were placed into a 3D printed mold (4 cm × 2 cm × 1.5 mm), treated
with vacuum until they froze, and dried by freeze-drying. For GelMA coating, the freezedried expanded nanofiber scaffolds were immersed in the 0.05% GelMA solution plus with
0.1% 2959 photocrosslinker which was added into the mold. Then, the scaffolds were
crosslinked with UV light for 45 s and dried by freeze-drying.

The 3D expanded nanofiber scaffolds with or without 0.05% GelMA coating were coated
with Pt for 5 min using a Pt sputter coater and imaged by SEM under 25 kV (FEI, Quanta
200, Hillsboro, OR, USA). Aluminum sheets confined the nanofiber scaffolds in different
compressive strains during the SEM imaging.
Cyclic compression tests.

Author Manuscript

The mechanical properties of 3D expanded nanofiber scaffolds with or without 0.05%
GelMA coating were measured by an Instron 5640 universal test machine. Samples (10 mm
× 10 mm × 10 mm) were used to perform the cyclic compressive tests. The compressive
strains were set as 50%, 70%, and 90%, respectively. The mechanical tests were run 1 cycle
with a speed of 9 mm/min. The superelastic property of 0.05% GelMA-coated, 3D expanded
nanofiber scaffolds were run 100 cycles with a speed of 9 mm/min under 90% compressive
strain. The elastic modulus was obtained based on the initial slope before 30% of
compressive strain. The recovery rate was calculated using the following equation. Recovery
rate (%) = (pore size after expansion / pore size before expansion) ×100 %
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The GFP-labeled human dermal fibroblasts were maintained in the low glucose DMEM
medium containing 10% FBS and 1% penicillin-streptomycin. Twenty milliliters of
fibroblast suspension solution (1×107 cells/ml) was first prepared. The 0.05% GelMAcoated, 3D expanded nanofiber scaffolds were put into the cell suspension solution and
treated with vacuum for 10 s. These nanofiber scaffolds were then removed from the cell
solution and placed into a 0.1% agar pretreated 6-well plate. The cell-seeded nanofiber
scaffolds were continuously cultured for 1, 3, 7, and 14 days. At each indicated time point, a
part of the scaffold (5 mm × 5mm) was cut by scissors, then it was put into a 24-well culture
plate, added 20 μl CCK-8 and continuously cultured for 3 h. The absorbance value at 450
nm was measured by a microplate reader.
BMSCs culture.

Author Manuscript

The rat BMSCs were isolated based on our established protocols and maintained in the low
glucose DMEM medium containing 10% FBS and 1% penicillin-streptomycin.30 Twenty
milliliters of BMSCs suspension solution (1×107 cells/ml) was prepared. The 0.05%
GelMA-coated, 3D expanded nanofiber scaffolds were put into the cell suspension solution
and treated with vacuum for 10 s. These nanofiber patch scaffolds were then removed from
the cell solution and placed into a 0.1% agar pretreated 6-well plate. The nanofiber patch
scaffolds were continuously cultured for 1, 3, 7, and 14 days respectively.
Human NSC culture.

Author Manuscript

Human NSCs were obtained from Millipore (Billerica, MA, USA). Laminin (20 μg/ml,
Invitrogen) was used to coat tissue culture plastic-ware at least 4 h before cell seeding to
promote the attachment of hNSCs. Cells were maintained in ReNcell Neural Stem Cell
Medium (Millipore) with FGF-2 (20 ng/ml) and EGF (20 ng/ml) at 37 °C under 5% CO2.
Then, 20 ml of hNSCs suspension with a concentration of 1×107 cell/ml were first prepared.
The 0.05% GelMA-coated, 3D expanded nanofiber scaffolds were immersed in the cell
suspension solution and treated with a vacuum for 10 s. The nanofiber scaffolds were then
removed from the cell solution and placed into a 0.1% agar pretreated 6-well plate, and
continuously cultured for 1 week. The culture medium was changed every two days. Then,
hNSCs were cultured in the medium in the presence of BDNF (20 ng/ml) and GDNF (20
ng/ml) for neuronal differentiation for another two weeks.
Confocal imaging.
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The GFP-labeled dermal fibroblasts seeded nanofiber scaffolds were directly imaged by
confocal laser scanning microscopy (CLSM) (Zeiss 880, Oberkochen, Germany) after
fixation with 4% paraformaldehyde. The BMSCs seeded nanofiber scaffolds were fixed with
4% paraformaldehyde and permeabilized with a 0.1% Triton X-100 solution. Subsequently,
the BMSCs were stained with Alexa Fluor™ 546 Phalloidin (dilution 1:200) for 20 min and
DAPI (dilution 1:2000) for 5 min. Then, the BMSCs seeded nanofiber scaffolds were
imaged by confocal microscopy. The hNSCs seeded nanofiber scaffolds were fixed with 4%
paraformaldehyde and permeabilized with 0.1% Triton X-100 in PBS solution for 20 min.
Next, the whole scaffolds were blocked with 5% goat serum for 30 min. The cells were then
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incubated with Tuj1 (1:100) primary antibody overnight, followed by incubation with goat
anti-mouse IgG H&L (Alexa Fluor® 546) secondary antibody (dilution 1:200) for 1 h and
DAPI (dilution 1:2000) for 5 min. Finally, cells-seeded scaffolds were imaged by confocal
microscopy. The confocal microscopy imaging parameters were set as follows. The z-stack
range was set from 0 μm to 125 μm. The interval was set at 5 μm. The tile scans were set as
7×7 for one region of the scaffold, and four regions of the scaffolds were imaged as shown
in Figure S4.
Demonstration of minimally invasive delivery.
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The glass tube for minimally invasive delivery was modified from Wilmad® NMR tube
(inner diameter = 4 mm). The BMSCs and hNSCs seeded nanofiber scaffolds (4 cm × 2 cm
× 1.5 mm) were compressed and loaded into the glass tube. Then, one end of the tube was
connected to an air source. The BMSCs and hNSCs seeded nanofiber scaffolds were pushed
into a culture dish containing medium. The viability of BMSCs and hNSCs before and after
delivery were evaluated by LIVE/DEAD assay. The BMSCs and hNSCs seeded nanofiber
scaffolds were incubated with LIVE/DEAD assay kit for 10 min, and then the scaffolds were
imaged under the confocal microscope. The cells stained with red color (dead cells) and all
cells in each image were counted, the apoptotic ratio of cells was calculated as following,
the apoptotic ratio (%) = (number of dead cells / number of all cells) %. Five randomly
selected images were used to quantify the apoptotic ratio.
Statistical analysis.
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All data were presented as mean ± standard deviation. The statistical analysis was performed
using GraphPad Prism 8.0 software. Differences between the two groups were evaluated
using Student’s t-test. The values of p < 0.05 were considered statistically significant. The
values of p < 0.01 were considered statistically very significant.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Schematic illustrating the fabrication of shape-recoverable 3D tissue constructs, and their
minimally invasive delivery. Procedures of fabrication of shape-recoverable 3D tissue
constructs and their minimally invasive delivery include generation of electrospun nanofiber
mat, expansion of nanofiber mat, GelMA coating, crosslinking, cell seeding, compression of
3D tissue constructs, loading into a cannula, injection, and shape-recovery.
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Figure 2.

3D expanded nanofiber scaffold fabrication and characterization. (a) Photograph showing
PCL nanofiber stripes (4 cm × 1.5 mm × 1 mm) before expansion. (b) Photograph showing a
3D expanded PCL nanofiber scaffold (4 cm × 1.5 mm × 2 cm). (c) SEM images showing 3D
expanded PCL nanofiber scaffolds without 0.05% GelMA coating, indicating the porous and
layered structure. (d) SEM images showing 3D expanded PCL nanofiber scaffolds with
0.05% GelMA coating, indicating the formation of hybrid nanofiber scaffolds with a porous
and layered structure. Red arrows indicate the direction of fiber alignment. Green arrow
heads indicate the formation of GelMA nanofibers.
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Figure 3.
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The superelastic and shape recoverable properties of 0.05% GelMA-coated, 3D expanded
PCL nanofiber scaffolds. (a) Photographs showing the flexible properties of 0.05% GelMAcoated, 3D expanded PCL nanofiber scaffolds. Cyclic compressive tests of 3D expanded,
PCL nanofiber scaffolds without (b) and with (c) 0.05% GelMA coating in 90% compressive
strain (100 cycles). (d) The maximum compressive stress of 3D expanded, PCL nanofiber
scaffolds without and with 0.05% GelMA coating in 50%, 70%, and 90% compressive
strain. (e) The elastic modulus of 3D expanded, PCL nanofiber scaffolds without and with
0.05% GelMA coating after the 1st, 25th, 50th, 75th, and 100th cyclic compression. SEM
images showing the corresponding 3D expanded, PCL nanofiber scaffolds without (f) and
with 0.05% GelMA coating (g) before compression, in different compressive strains, and
after release of compressive strains. 3D expanded, PCL nanofiber scaffolds without 0.05%
GelMA coating failed to completely recover the shape after release of compressive strains.
3D expanded PCL nanofiber scaffolds with 0.05% GelMA coating could fully recover after
release of compressive strains. Red dot lines indicate the contours of pores before
compression. Green dot lines indicate the original shapes of pores after compression and
release of compressive strain.
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Figure 4.
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Cell culture on 3D expanded nanofiber scaffolds (2 cm × 2 cm ×1.5 mm). (a) Conformal
microscopy images showing BMSCs in different regions of square-shaped nanofiber
scaffolds. The depth imaged was 125 μm. Inset: highly magnified images of BMSCs seeded
on nanofiber scaffolds. Cells were stained with Alexa Fluor™ 546 Phalloidin in red, and cell
nuclei were stained with DAPI in blue. (b) Conformal microscopy images showing hNSCs
in different regions of square-shaped nanofiber scaffolds after proliferation for 7 days and
neuronal differentiation for another 14 days. Inset: The formation of 3D neuronal networks
on the scaffolds after neuronal differentiation for 14 days. Cells were stained with Tuj1 for
neurons in red, and cell nuclei were stained with DAPI in blue.
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Figure 5.

Demonstration of minimally invasive delivery of 3D tissue constructs and the effect of
delivery on the cell viability. (a (i)) Photograph showing a 3D tissue construct consisting of
0.05% GelMA-coated, 3D expanded nanofiber scaffolds seeded with BMSCs in a petri dish.
(a (ii, iii)) Photographs showing glass tubes for injection of 3D tissue constructs. (a (iv, v))
Photographs showing the 3D tissue construct was loaded into the glass tube and then
injected into the petri dish containing culture medium using an air source. (a (vi))
Photograph showing the injected 3D tissue construct returned to its original shape. (b) LIVE/
DEAD staining of BMSCs seeded on 0.05% GelMA-coated, 3D expanded nanofiber
scaffolds before and after injection. (c) Quantification of live BMSCs before and after
injection.
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